After five years of design and two years in development, breakthrough psoriasis treatment Prosoria is now shipping thousands of units to customers, Fort Worth-based biotech company Nuvothera said in a news release.
Psoriasis is a chronic inflammatory autoimmune disease that results in excessive growth of skin cells. The World Health Organization said the aliment affects more than over 125 million people worldwide
Art Clapp, president and CEO of Nuvothera Inc., said more than 85 percent of psoriasis patients say they wish they had better, longer lasting and more affordable therapies, but side-effect concerns remain paramount.
With Prosoria, psoriasis sufferers have a clinically proven, powerful and safe over-the-counter treatment option that includes natural ingredients and can be conveniently applied just once per day for full effectiveness, Clapp said.
Psoriasis can strike anywhere on the body, with any amount of surface coverage, and yields thick red skin patches and scaling. Beyond itching, pain, and increased risk of infection, psoriasis victims face incessant social worries, especially embarrassment and isolation, the company said in a news release.
Very little has changed in psoriasis treatments over the last 50 years, and while the vast majority of psoriasis sufferers are unsatisfied with their treatment options, they have had little to no recourse, the company said.
Clapp holds degrees in biochemistry and business and spent more than 20 years at Galderma, learning the pharma industry from sales and marketing through product and commercial development.
For mild to moderate psoriasis sufferers looking for topical treatment, Prosoria offers a superior, sustainable way to control symptoms without the common complaints that plague other options, the news release said.
Prosoria delivers a more powerful approach needed when treating a tougher condition like psoriasis, but safely. Prosoria harnesses the effectiveness of combination therapy along with potent psoriasis fighting ingredients that relieve psoriasis symptoms and help control future flares.
“The secret is the system. The power is in the combination,” Clapp said in the news release.
Prosoria is the market’s first once-daily treatment system for psoriasis and includes individual products that are easy and convenient for daily use and take less than 60 seconds to apply.
The products are clinically proven and dermatologist tested, the release said, and has earned the seal of recognition from the National Psoriasis Foundation (NPF).
“Our passion for how our products can impact people’s lives is what drives us,” said Bev Hope, director of marketing. “Nothing makes us happier than hearing from our Prosoria users and seeing their amazing results.”
“It’s been a long road to find Prosoria’s ideal mix of ingredients and application experience, but everything we’re hearing back tells us it was worth it,” says Clapp. “I’m so excited to help people with this problem, and there’s no shortage of related skin needs we can help with in the near future.”
Nuvothera was formed by dermatology pharmaceutical executives with the mission of developing novel OTC products for chronic, difficult-to-treat diseases such as psoriasis.
Clapp was named Entrepreneur of the Year by the Fort Worth Business Press in 2018 . Nuvothera also won the Tech FW (Fort Worth) Impact Award.
– FWBP staff
For more on the company: